Hmm I thought the only unsatisfactory result is the fall in gross margin, which is a result of some non-recurring expenses[思考]
Bionano Genomics stock tanked more than 8% in premarket trading
Bionano Genomics stock tanked more than 8% in premarket trading after Bionano Genomics Q3 net loss $
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
3
举报
登录后可参与评论
![empty](https://c1.itigergrowtha.com/community/assets/media/empty-default.06ba11e0.png)
暂无评论